SAFETY OF TOFACITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN PATIENTS FROM LATIN AMERICA AND THE REST OF THE WORLD

被引：0
|
作者：
Castaneda, O. [1 ]
Jaller, J. [2 ]
Citera, G. [3 ]
Radominski, S. C. [4 ,5 ]
Cardiel, M. H. [6 ]
Zerbini, C. A. F. [7 ]
Guzman, R. [8 ,9 ]
Solano, G. [10 ]
Belini, M. [11 ]
Maniccia, A. [12 ]
Kwok, K. [12 ]
Rojo, R. [13 ]
Ponce de Leon, D. [14 ]
机构：
[1] Clin Angloamer, Lima, Peru
[2] Ctr Reumatol & Ortopedia, Barranquilla, Colombia
[3] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina
[4] Univ Fed Parana, Curitiba, Parana, Brazil
[5] CETI, Curitiba, Parana, Brazil
[6] Ctr Invest Clin Morelia, Morelia, Michoacan, Mexico
[7] Ctr Paulista Invest Clin, Sao Paulo, Brazil
[8] Fdn Univ Juan N Corpas, Immunol Dept, Bogota, Colombia
[9] IDEARG, Bogota, Colombia
[10] Pfizer Inc, San Jose, Costa Rica
[11] Pfizer Inc, Buenos Aires, DF, Argentina
[12] Pfizer Inc, New York, NY USA
[13] Pfizer Inc, Groton, CT 06340 USA
[14] Pfizer Inc, Lima, Peru
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1793
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0396
引用
收藏
页码：1041 / 1041
页数：1
相关论文
共 50 条
  • [1] Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population
    Castaneda, Oswaldo M.
    Romero, Felix J.
    Salinas, Ariel
    Citera, Gustavo
    Mysler, Eduardo
    Rillo, Oscar
    Radominski, Sebastiao C.
    Cardiel, Mario H.
    Jaller, Juan J.
    Alvarez-Moreno, Carlos
    Ponce de Leon, Dario
    Castelli, Graciela
    Garcia, Erika G.
    Kwok, Kenneth
    Rojo, Ricardo
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (04) : 193 - 199
  • [2] REAL WORLD USE OF TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM LATIN AMERICA
    Schneeberger, E. E.
    Salas, A.
    Medina, L. F.
    Zacariaz, J. B.
    Mantilla, R. D.
    Sarmiento-Monroy, J. C.
    Elizondo, L. J.
    Garro, B.
    Madariage, H.
    Gorriz, L.
    Giorgi, R. D. N.
    Pinheiro, M.
    Ponce de Leon, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1196 - 1197
  • [3] REAL-WORLD USE OF TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM LATIN AMERICA
    Schneeberger, E. E.
    Salas, A.
    Medina, L. F.
    Zacariaz, J. B.
    Mantilla, R. D.
    Sarmiento-Monroy, J. C.
    Elizondo, L. J.
    Garro, B.
    Madariaga, H.
    Gorriz, L.
    Giorgi, R. D. N.
    Butte, K.
    Ventura, R.
    Tate, P.
    Ranza, R.
    Coronado, P.
    Forero, E.
    Rodrigues, W.
    Roa, Y.
    Larroude, M.
    Vasquez, R.
    Belini, A.
    Amador, L.
    Solano, G.
    Sanguino, F.
    Aracena, G.
    Ponce de Leon, D.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S73 - S74
  • [4] TOFACITINIB IN RHEUMATOID ARTHRITIS: AN UPDATED ANALYSIS OF REAL-WORLD DATA IN LATIN AMERICA
    Anzueto, Estuardo
    Maria Rivera, Silvia
    Asnal, Cecilia
    Cruz, Luis Javier
    Caicedo, Tomas
    Felipe, Oscar
    Maria Ventura, Rosa
    del Rosario Maliandi, Maria
    Hadid, Jaime
    Huamanchumo, Roberto
    Ponce de Leon, Dario
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S50 - S50
  • [5] Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis
    Lundquist, Lisa M.
    Cole, Sabrina W.
    Sikes, Martha L.
    [J]. WORLD JOURNAL OF ORTHOPEDICS, 2014, 5 (04): : 504 - 511
  • [6] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [7] EFFICACY, SAFETY AND SURVIVAL OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA
    Isnardi, C.
    Schneeberger, E.
    Casado, C.
    Smichowski, A.
    Romeo, C.
    Rivero, E.
    Caputo, V.
    Soriano, E.
    Zacariaz, J.
    Pierini, F.
    Garcia, M.
    Savy, F.
    Citera, G.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 126 - 126
  • [8] Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
    Mark C. Genovese
    Ronald F. van Vollenhoven
    Bethanie Wilkinson
    Lisy Wang
    Samuel H. Zwillich
    David Gruben
    Pinaki Biswas
    Richard Riese
    Liza Takiya
    Thomas V. Jones
    [J]. Arthritis Research & Therapy, 18
  • [9] Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
    Genovese, Mark C.
    van Vollenhoven, Ronald F.
    Wilkinson, Bethanie
    Wang, Lisy
    Zwillich, Samuel H.
    Gruben, David
    Biswas, Pinaki
    Riese, Richard
    Takiya, Liza
    Jones, Thomas V.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [10] Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
    Li, Zhan-Guo
    Liu, Yi
    Xu, Hu-Ji
    Chen, Zhi-Wei
    Bao, Chun-De
    Gu, Jie-Ruo
    Zhao, Dong-Bao
    An, Yuan
    Hwang, Lie-Ju
    Wang, Lisy
    Kremer, Joel
    Wu, Qi-Zhe
    [J]. CHINESE MEDICAL JOURNAL, 2018, 131 (22) : 2683 - +
12345